THE END-STAGE RENAL-DISEASE SEVERITY INDEX (ESRD-SI)

被引：53
|
作者：
CRAVEN, J [1 ]
LITTLEFIELD, C [1 ]
RODIN, G [1 ]
MURRAY, M [1 ]
机构：
[1] UNIV TORONTO,TORONTO HOSP,DEPT NEPHROL,TORONTO,ONTARIO,CANADA
来源：
PSYCHOLOGICAL MEDICINE | 1991年 / 21卷 / 01期
关键词：
D O I：
10.1017/S0033291700014823
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
Measures of disease severity are required as experimental, control and outcome variables in studies of the psychosocial aspects of physical illness. The Endstage Renal Disease Severity Index (ESRD-SI) was developed for these purposes during a prospective study of patient adjustment to dialysis and endstage renal disease (ESRD). It was found to have adequate inter-rater reliability, test-retest reliability, and construct and predictive validity in two subsamples (total N = 233) of dialysis patients. The ESRD-SI is suitable as a sensitive indicator of disease severity in these patients.
引用
收藏
页码：237 / 243
页数：7
相关论文
共 50 条
  • [1] MANAGEMENT OF END-STAGE RENAL-DISEASE (ESRD)
    FALLS, WF
    [J]. MEDICAL COLLEGE OF VIRGINIA QUARTERLY, 1978, 14 (02): : 92 - 95
  • [2] ANEMIA OF END-STAGE RENAL-DISEASE (ESRD)
    ESCHBACH, JW
    ADAMSON, JW
    [J]. KIDNEY INTERNATIONAL, 1985, 28 (01) : 1 - 5
  • [3] MEASURING DISEASE SEVERITY IN PATIENTS WITH END-STAGE RENAL-DISEASE - VALIDITY OF THE CRAVEN ET-AL ESRD SEVERITY INDEX
    GRIFFIN, KW
    FRIEND, R
    WADHWA, NK
    [J]. PSYCHOLOGICAL MEDICINE, 1995, 25 (01) : 189 - 193
  • [4] HYPERTENSIVE END-STAGE RENAL-DISEASE (ESRD) - WHERES THE PROOF
    SCHLESSINGER, SD
    TANKERSLEY, MR
    CURTIS, JJ
    [J]. CLINICAL RESEARCH, 1993, 41 (04): : A794 - A794
  • [5] PLATELET-FUNCTION IN END-STAGE RENAL-DISEASE (ESRD)
    PEREZ, A
    SANCHEZ, M
    LINARES, M
    CERVERO, A
    ESCOBEDO, JM
    GARCES, L
    VILLARO, J
    MOLL, R
    SANCHIS, J
    [J]. KIDNEY INTERNATIONAL, 1988, 34 (02) : 291 - 291
  • [6] CAPTOPRIL THERAPY OF HYPERTENSION IN END-STAGE RENAL-DISEASE (ESRD)
    LESLIE, BR
    CASE, DB
    VAUGHAN, ED
    SULLIVAN, JF
    [J]. KIDNEY INTERNATIONAL, 1979, 16 (06) : 906 - 906
  • [7] LIPOPROTEIN (A) [LP(A)] IN PATIENTS WITH END-STAGE RENAL-DISEASE (ESRD)
    KOCH, M
    BOLLMANN, S
    KUTKUHN, B
    GRABENSEE, B
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 543 - 543
  • [8] END-STAGE RENAL-DISEASE (ESRD) IN PATIENTS WITH EATING DISORDERS
    ABDELRAHMAN, EM
    MOORTHY, AV
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 410 - 410
  • [9] HYPERTENSIVE END-STAGE RENAL-DISEASE (ESRD) IN A LARGE POPULATION
    MCCLELLAN, W
    TUTTLE, E
    ISSA, A
    [J]. KIDNEY INTERNATIONAL, 1986, 29 (01) : 197 - 197
  • [10] TRENDS IN INCIDENCE AND PREVALENCE OF END-STAGE RENAL-DISEASE (ESRD)
    WELLER, JM
    WU, SC
    FERGUSON, CW
    HAWTHORNE, VM
    [J]. KIDNEY INTERNATIONAL, 1983, 23 (01) : 140 - 140
12345